Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.56B |
| 2 |
Amazon
AMZN
|
+$1.34B |
| 3 |
Eli Lilly
LLY
|
+$1.26B |
| 4 |
NVIDIA
NVDA
|
+$1.08B |
| 5 |
Chevron
CVX
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$964M |
| 2 |
ANSS
Ansys
ANSS
|
+$924M |
| 3 |
Johnson & Johnson
JNJ
|
+$753M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$418M |
| 5 |
American Express
AXP
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.52% |
| 2 | Financials | 13.57% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Communication Services | 9.71% |
| 5 | Healthcare | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNS
3951
Jupiter Neurosciences
JUNS
$3.55M
| $183K | ﹤0.01% |
+1,384
| New | +$157K |
|
|
WTF
3952
Waton Financial Ltd
WTF
$141M
| $182K | ﹤0.01% |
29,578
+14,379
| +95% | +$74.6K |
|
|
NVNO
3953
enVVeno Medical
NVNO
$7.5M
| $182K | ﹤0.01% |
5,750
+50
| +0.9% | +$5.11K |
|
|
CARV
3954
DELISTED
Carver Bancorp
CARV
| $182K | ﹤0.01% |
76,070
+4,425
| +6% | +$9.35K |
|
3955
CAMP4 Therapeutics
CAMP
$284M
| $181K | ﹤0.01% |
60,371
-14,828
| -20% | -$27.5K |
|
|
GTEN
3956
Gores Holdings X
GTEN
$482M
| $181K | ﹤0.01% |
+17,677
| New | +$181K |
|
|
SVII
3957
DELISTED
Spring Valley Acquisition Corp II
SVII
| $180K | ﹤0.01% |
14,415
| – | – |
|
3958
Bridgford Foods
BRID
$57.4M
| $180K | ﹤0.01% |
22,651
-1
| -0% | -$8 |
|
3959
MultiSensor AI
MSAI
$11.3M
| $180K | ﹤0.01% |
6,977
+1,190
| +21% | +$34.7K |
|
|
LNAI
3960
Lunai Bioworks
LNAI
$10.7M
| $180K | ﹤0.01% |
15,818
+3,119
| +25% | +$60.1K |
|
3961
MiNK Therapeutics
INKT
$56.6M
| $179K | ﹤0.01% |
12,806
+1,314
| +11% | +$21K |
|
|
BRR
3962
ProCap Financial Inc
BRR
$161M
| $178K | ﹤0.01% |
17,599
-17,547
| -50% | -$180K |
|
|
RBOT
3963
DELISTED
Vicarious Surgical
RBOT
| $177K | ﹤0.01% |
32,150
-284
| -0.9% | -$2.17K |
|
|
SUIG
3964
Sui Group Holdings
SUIG
$68.9M
| $177K | ﹤0.01% |
+45,829
| New | +$207K |
|
3965
Q32 Bio
QTTB
$458M
| $175K | ﹤0.01% |
88,496
+26,897
| +44% | +$51.7K |
|
3966
Cadrenal Therapeutics
CVKD
$6.56M
| $175K | ﹤0.01% |
12,710
| – | – |
|
3967
Lipocine
LPCN
$17M
| $175K | ﹤0.01% |
61,076
| – | – |
|
|
ANTA
3968
Antalpha Platform Holding Co
ANTA
$96.3M
| $174K | ﹤0.01% |
14,301
| – | – |
|
3969
Shimmick
SHIM
$167M
| $174K | ﹤0.01% |
66,757
+22,762
| +52% | +$55.9K |
|
3970
SAB Biotherapeutics
SABS
$346M
| $172K | ﹤0.01% |
85,718
+946
| +1% | +$2.14K |
|
|
TDAC
3971
Translational Development Acquisition Corp
TDAC
$238M
| $171K | ﹤0.01% |
16,554
| – | – |
|
|
TAOX
3972
Tao Synergies Inc
TAOX
$26M
| $171K | ﹤0.01% |
26,110
+14,995
| +135% | +$108K |
|
3973
Alpha Tau Medical
DRTS
$1.25B
| $171K | ﹤0.01% |
37,893
| – | – |
|
3974
A2Z Smart Technologies
AZ
$288M
| $171K | ﹤0.01% |
21,354
| – | – |
|
|
NYC
3975
American Strategic Investment Co
NYC
$24M
| $171K | ﹤0.01% |
17,002
-4,569
| -21% | -$55.6K |
|
Similar funds
Geode Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Geode Capital Management held 4,592 positions worth $1.57T, up 9.9% from $1.43T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Geode Capital Management's Q3 2025 filing shows 148 new, 2,907 increased, 1,130 reduced and 119 closed positions. Its largest new stake was Paramount Skydance Corp: 8,343,504 shares worth $158M. The largest sale was Hess, an estimated $964M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q3 2025 buy was Paramount Skydance Corp: 8,343,504 shares worth $158M.
- Geode Capital Management added most to Applovin in Q3 2025, an estimated $1.56B increase.
- Geode Capital Management's biggest Q3 2025 reduction was Johnson & Johnson, cutting an estimated $753M.
- Geode Capital Management fully exited Hess in Q3 2025, selling an estimated $964M.
- Geode Capital Management's ten largest holdings make up 34% of its $1.57T portfolio in Q3 2025.
- Geode Capital Management opened 148 new positions and closed 119 in Q3 2025.
- Geode Capital Management's portfolio value rose 9.9% quarter-over-quarter to $1.57T.
Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.